Prognostic value of the number and laterality of metastatic inguinal lymph nodes in vulvar cancer: Revisiting the FIGO staging system

被引:31
作者
Baiocchi, G. [1 ]
Silva Cestari, F. M. [1 ]
Rocha, R. M. [2 ]
Lavorato-Rocha, A. [2 ]
Maia, B. M. [2 ]
Cestari, L. A. [1 ]
Kumagai, L. Y. [1 ]
Faloppa, C. C. [1 ]
Fukazawa, E. M. [1 ]
Badiglian-Filho, L. [1 ]
Sant'Ana Rodrigues, I. [2 ]
Soares, F. A. [2 ]
机构
[1] Hosp Canc AC Camargo, Dept Ginecol Oncol, BR-01509010 Sao Paulo, Brazil
[2] Hosp Canc AC Camargo, Dept Anat Pathol, BR-01509010 Sao Paulo, Brazil
来源
EJSO | 2013年 / 39卷 / 07期
关键词
Vulvar cancer; Lymph node metastasis; Lymphadenectomy; Prognosis; Tumor staging; SQUAMOUS-CELL CARCINOMA; SURVIVAL; IMPACT;
D O I
10.1016/j.ejso.2013.03.004
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: Inguinal lymph node (LN) metastasis is an important prognostic factor in vulvar cancer. Our aims were to analyze the prognostic value of LN metastasis with regard to the number of LNs that were involved and their laterality and compare these results with the current FIGO staging system. Methods: A retrospective analysis was performed in a series of 234 individuals who underwent inguinal lymphadenectomy for vulvar squamous cell carcinoma from January 1980 to February 2010. Results: The mean age was 68 years. One hundred seven (45.7%) patients had LN metastasis. Despite the FIGO staging, we did not observe any significant difference in the risk of recurrence or death between patients with 1 positive LN and >= 2 positive LNs. Moreover, there was no difference in outcome between the presence of 1 and 2 positive LNs. On categorizing patients into 3 groups-absence of LN involvement, 1-2 positive LNs, and >= 3 positive LNs-we achieved a significantly better prognostic correlation for progression-free survival, disease-specific survival, and overall survival. Extracapsular spread retained a prognostic role for the risk of recurrence in multivariate analysis. Further, for patients with >= 2 positive LNs, the presence of bilateral positive LNs did not negatively impact the risk of recurrence or death compared with those with unilateral positive LNs. Conclusions: Our data suggest that the prognostic effect of bilateral LNs reflects the worse prognosis of multiple positive LNs. Regarding prognosis, LN involvement should be categorized into 2 groups-1-2 positive LNs and >= 3 positive LNs. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:780 / 785
页数:6
相关论文
共 18 条
[1]  
[Anonymous], BEREK HACKERS GYNECO
[2]   PROGNOSTIC FACTORS IN CARCINOMA OF THE VULVA [J].
BOYCE, J ;
FRUCHTER, RG ;
KASAMBILIDES, E ;
NICASTRI, AD ;
SEDLIS, A ;
REMY, JC .
GYNECOLOGIC ONCOLOGY, 1985, 20 (03) :364-377
[3]   THE IMPORTANCE OF THE GROIN NODE STATUS FOR THE SURVIVAL OF T1 AND T2 VULVAR CARCINOMA PATIENTS [J].
BURGER, MPM ;
HOLLEMA, H ;
EMANUELS, AG ;
KRANS, M ;
PRAS, E ;
BOUMA, J .
GYNECOLOGIC ONCOLOGY, 1995, 57 (03) :327-334
[4]   Surgery and radiotherapy in vulvar cancer [J].
de Hullu, J. A. ;
van der Zee, A. G. J. .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2006, 60 (01) :38-58
[5]   Prognostic Value of Bilateral Positive Nodes in Squamous Cell Cancer of the Vulva [J].
Fons, Guus ;
Hyde, Simon E. ;
Buist, Marrije R. ;
Schilthuis, Marten S. ;
Grant, Peter ;
Burger, Matthe P. M. ;
van der Velden, Jacobus .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2009, 19 (07) :1276-1280
[6]   Revised FIGO staging for carcinoma of the vulva [J].
Hacker, Neville F. .
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2009, 105 (02) :105-106
[7]  
HACKER NF, 1983, OBSTET GYNECOL, V61, P408
[8]   ASSESSMENT OF CURRENT INTERNATIONAL FEDERATION OF GYNECOLOGY AND OBSTETRICS STAGING OF VULVAR CARCINOMA RELATIVE TO PROGNOSTIC FACTORS FOR SURVIVAL (A GYNECOLOGIC ONCOLOGY GROUP-STUDY) [J].
HOMESLEY, HD ;
BUNDY, BN ;
SEDLIS, A ;
YORDAN, E ;
BEREK, JS ;
JAHSHAN, A ;
MORTEL, R .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1991, 164 (04) :997-1004
[9]   A COMPARISON OF STAGING SYSTEMS FOR SQUAMOUS-CELL CARCINOMA OF THE VULVA [J].
HOPKINS, MP ;
REID, GC ;
JOHNSTON, CM ;
MORLEY, GW .
GYNECOLOGIC ONCOLOGY, 1992, 47 (01) :34-37
[10]  
PALADINI D, 1994, CANCER-AM CANCER SOC, V74, P2491, DOI 10.1002/1097-0142(19941101)74:9<2491::AID-CNCR2820740916>3.0.CO